Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

380 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complete response and long-term survival after short-course camrelizumab plus apatinib, hepatic arterial infusion chemotherapy, and transarterial chemoembolization in large and advanced hepatocellular carcinoma: a case report.
Qiao JH, Wang Y, Fu CX, Yang JD, Takemura N, Zheng WH. Qiao JH, et al. Among authors: takemura n. J Gastrointest Oncol. 2024 Oct 31;15(5):2323-2329. doi: 10.21037/jgo-24-613. Epub 2024 Oct 14. J Gastrointest Oncol. 2024. PMID: 39554580 Free PMC article.
A Multicenter Phase 2 Trial Evaluating the Efficacy and Safety of Preoperative Lenvatinib Therapy for Patients with Advanced Hepatocellular Carcinoma (LENS-HCC Trial).
Ichida A, Arita J, Hatano E, Eguchi S, Saiura A, Nagano H, Shindoh J, Hashimoto M, Takemura N, Taura K, Sakamoto Y, Takahashi Y, Seyama Y, Sasaki Y, Uemura K, Kokudo N, Hasegawa K. Ichida A, et al. Among authors: takemura n. Liver Cancer. 2023 Nov 28;13(3):322-334. doi: 10.1159/000535514. eCollection 2024 Jun. Liver Cancer. 2023. PMID: 38894811 Free PMC article.
Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: The Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery Expert Consensus Statement 2023.
Akahoshi K, Shindoh J, Tanabe M, Ariizumi S, Eguchi S, Okamura Y, Kaibori M, Kubo S, Shimada M, Taketomi A, Takemura N, Nagano H, Nakamura M, Hasegawa K, Hatano E, Yoshizumi T, Endo I, Kokudo N. Akahoshi K, et al. Among authors: takemura n. Liver Cancer. 2024 Mar 29;13(6):0-10. doi: 10.1159/000538627. eCollection 2024 Dec. Liver Cancer. 2024. PMID: 39524972 Free PMC article.
Protocol of the RACB study: a multicenter, single-arm, prospective study to evaluate the efficacy of resection of initially unresectable hepatocellular carcinoma with atezolizumab combined with bevacizumab.
Okuno M, Ishii T, Ichida A, Soyama A, Takemura N, Hirono S, Eguchi S, Hasegawa K, Sasaki Y, Uemura K, Kokudo N, Hatano E. Okuno M, et al. Among authors: takemura n. BMC Cancer. 2023 Aug 21;23(1):780. doi: 10.1186/s12885-023-11302-6. BMC Cancer. 2023. PMID: 37605169 Free PMC article.
A case of pseudomyxoma peritonei arising from a perforated intraductal papillary mucinous neoplasm that underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Yoshizaki Y, Gohda Y, Inagaki F, Kataoka A, Takemura N, Miyazaki H, Igari T, Kiyomatsu T, Yano H, Kokudo N. Yoshizaki Y, et al. Among authors: takemura n. Clin J Gastroenterol. 2024 Feb;17(1):188-197. doi: 10.1007/s12328-023-01890-y. Epub 2023 Nov 18. Clin J Gastroenterol. 2024. PMID: 37980306
380 results